Using technology in combination with behavioral science licensed from Duke University, Raleigh startup Improved Patient Outcomes says it has developed solutions to combat non-adherence to medication by patients.
Take your meds, improve your health – that’s part of the message the startup will present at the CED Tech Venture conference.
For a quick overview, see a newly published overview video at YouTube: https://www.youtube.com/watch?v=YBljY_XzKQU
Here’s a Q&A about Improved Patient Outcomes, presented as part of a partnership between the CED and WRAL TechWire.
- What is the focus of your business?
Improving Patient Outcomes and lowering healthcare costs by marrying behavioral science and technology.
- What is the top pain point/business application you are seeking to address?
We increase patient adherence to medication by 25% or more. Medication non-adherence is a $ 300 billion problem annually.
- What makes it unique?
We use mobile apps, web, email, sms, phone, pharmacist and other forms of patient engagement combined with 20 years of behavioral research to change patient behavior.
- Why should investors be interested in your firm?
Our behavioral science is part of an exclusive license from Duke University School of Medicine developed with over $80mm in funding and proven to work in over 70 programs with 20,000+ patients. Relative risk is low and management is well-versed in lifecycle of startup to growth stage and beyond.
Business facts:
- Website – http://www.IPOHealthMatters.com
- Email address for inquiries – clients@IPOHealthMatters.com
- Physical address – Raleigh, NC
- CEO – Gregory A. Muffler